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AN EXPERIMENTAL STUDY OF ANTIBIOTICS FOR THEIR
ACTIVITY IN THE SHWARTZMAN PHENOMENON*
GRACE P. KERBY, M.D. AND JOHN C. MULLER, M.D.
The current use of antibiotics by various routes in the same patient offers a
theoretically sound situation for the development of Shwartzman reactions, if
the antibiotics contain Shwartzman potent material. In certain patients dying
from infection in spite of the intensive use of antibiotics, lesions are present
which suggest the possibility of Shwartzman phenomena. Boelter and Hatoff
(1) report such a case.
If antibiotic contained Shwartzman material, the reaction might occur in one
of at least three ways: (1) with an antibiotic acting as both the preparatory and
the provocative agent; (2) with the antibiotic acting as the preparatory agent,
and material produced by the infecting organism acting to provoke the reaction;
and (3) with the infecting organism producing the preparatory material, and the
antibiotic acting as the provocative agent.
The present study was designed to detect the presence of Shwartzman potent
material in penicillin, aureomycin, streptomycin, chioromycetin and terramycin.
Shwartzman's monograph (2) gives a detailed description of the phenomenon
under discussion, and Black-Schaffer has more recently discussed (3) its possible
clinical applications. Becker (4) has investigated various agents including peni-
cillin and streptomycin for their suppressive effect on the Shwartzman reaction.
He observed no suppression with the antibiotics as used parenterally while
eliciting the Shwartzman reaction in the conventional manner, using a meningo-
coccal filtrate and endotoxin as the preparatory and provocative agents.
EXPERIMENTS AND RESULTS
Meningococcal filtrate of known high Shwartzman potency was donated by
B. Black-Schaffer for this study. The method of its preparation has been de-
scribed (5).
The following test materials were used: Lederle Aureomycin Intravenous with
1( —) leucine solution 2.6%; Wyeth Dihydrostreptomycin Sulfate; Bristol Peni-
cillin Crystalline G; Chloromycetin Kapseals and Crystalline Chloromycetin;'
Terramycin Hydrochloride.2 Saline was used as the solute or suspending medium
except as noted for aureomycin. Chloromycetin Kapseals, Crystalline Chloro-
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mycetin and Terramycin Hydrochloride were ground in a Ten Broeck grinder
before being suspended in saline.
The test animals were 1.3 to 2.3 kilo healthy albino rabbits. The abdominal
fur was clipped (but not shaven) closely with electric clippers, to assure adequate
visualization of the reaction sites without skin trauma.
The intradermal inoculation was 0.15 ml. of material in all instances. This was
followed in 21 to 24 hours by the intravenous injection of 0.3 to 2.7 ml. of ma-
terial. In each animal the concentration of the provocative material used was the
same as that of the corresponding preparatory material, except in the case of
chloromycetin where the provocative dose was half the concentration of the pre-
paratory dose.
Group I: Ten rabbits received a provocative intravenous injection of meningo-
coccal filtrate (0.5 ml.) approximately 24 hours after having received prepara-
tory intradermal injections (0.15 ml.) of meningococcal filtrate and of various
antibiotics as noted herewith:
Four rabbits: Penicillin 30,000 units, aureomycin 2 mgm.
Three rabbits: Streptomycin 15 mgm. of base.
Three rabbits: Chioromycetin 15 mgm., terramycin 15 mgm.
In no instance in these animals was a Shwartzman reaction observed at a
local site prepared with an antibiotic. One animal died before a local reaction
could develop. The remaining nine animals showed a Shwartzman reaction at
the locally prepared meningococcal filtrate site. The reactions were marked in
all but one instance in which a weakly positive reaction was obtained.
Group II: Fifteen rabbits were divided into five subgroups of three animals
to receive provocative intravenous injections of the following antibiotics:
Penicillin 540,000 units.
Aureomycin 24 mgm.
Streptomycin 300 mgm.
Chloromycetin Kapseal 100 mgm.3
Aureomycin 12.5 mgm.3
In each instance the provocative injection was preceded 24 hours before by the
preparatory intradermal injection of the corresponding antibiotic and of menin-
gococcal filtrate. Six mgm. of aureomycin were used; the other preparatory in-
jections were the same as were used in Group I.
Penicillin, aureomycin and terramycin failed to provoke a Shwartzman reac-
tion at sites locally prepared with the corresponding antibiotic and with menin-
gococcal filtrate. In one of the three rabbits given streptomycin intravenously,
a very small area of hemorrhage was observed 4 hours later at the site prepared
locally with meningococcal filtrate. Nothing suggestive of a Shwartzman reac-
tion was observed at any other site prepared locally with either streptomycin or
meningococcal filtrate. In one of the two surviving rabbits given chloromycetin
Kapseal intravenously, petechiae were observed 8 hours later and a 2 x 2.5 cm.
GOne animal in each of these subgroups convulsed and died immediately after receiving
intravenously 200 mgm. of the antibiotic. The remaining two animals in each subgroup
received a lesser dose as indicated without apparent adverse effect.
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area of hemorrhage 17 hours after the intravenous injection at the site prepared
locally with meningococcal filtrate. No Shwartzman reaction was observed at
any other site prepared locally with either chioromycetin Kapseal or meningo-
coccal filtrate.
Group III: Eighteen rabbits were divided into three subgroups to receive
provocative intravenous injections of the following antibiotics:
Streptomycin 300 mgm.
Chioromycetin Kapseal 100 mgm.
Chloromycetin Crystalline 100 mgm.
In each instance the provocative injection was preceded 24 hours before by
the preparatory injection of the corresponding antibiotic and of meningococcal
filtrate.
No Shwartzman reaction was provoked at any of the above locally prepared
sites.
Forty hours later, each animal in Groups II and III was again prepared locally
with the meningococcal filtrate and 24 hours later was given meningococcal
filtrate intravenously in order to establish the ability of each animal to react to
Shwartzman material. Twelve of the 13 rabbits in Group II proved to be strong
Shwartzman reactors. The thirteenth rabbit reacted weakly to the material. All
of the 6 rabbits in the streptomycin subgroup of Group III were demonstrated
similarly to be strong reactors to meningococcal filtrate. Five of the 6 rabbits in
the chioromycetin Kapseal subgroup and 1 of the 6 rabbits in the chioromycetin
crystalline subgroup expired after intravenous meningococcal filtrate before a
positive reaction could develop. The deaths were attributed to a blocking effect
by the particulate chioromycetin used, such that the potent meningococcal fil-
trate remained in the circulating blood longer than normally (6). The remaining
chloromycetin rabbits proved to be strong reactors on testing with meningococcal
filtrate.
DISCUSSION
By conventional methods for the production of the Shwartzman reaction in
the rabbit, we have been unable to demonstrate either preparatory or provocative
potency in any of the antibiotics tested in the present study. In each instance a
meningococcal filtrate of known high Shwartzman potency was used either as
the preparatory or the provocative agent, and the ability of every rabbit used
to react to the Shwartzman material was established subsequently. In one of
nine rabbits given streptomycin intravenously, a very small area of hemorrhage
was observed 4 hours later at the meningococcal filtrate prepared site. The reac-
tion was not conclusively positive, however. In one of nine rabbits given chloro-
mycetin Kapseal intravenously, a definite but delayed Shwartzman reaction
developed in the meningococcal filtrate prepared site. No reaction was obtained
in six rabbits given chloromycetin crystalline intravenously. The single positive
reaction observed may have been due to the starch present in chioromycetin
Kapseals (2). No positive reactions were observed using aureomycin, penicillin
or terramycin.
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The antibiotic preparations were those commonly employed clinically at the
present time. Some of the earlier, more crude preparations might well be more
likely to show Shwartzman potency. However, this study was undertaken pri-
marily to determine the possible complications involved in using the medications
at hand. By the methods applied here for testing Shwartzman potency, this
particular complication could not be demonstrated as a hazard in the use of
these drugs.
SUMMARY
1. By conventional methods of testing in the rabbit for Shwartzman potency,
no Shwartzman active principle could he demonstrated in penicillin crystalline
G, dihydrostreptomycin sulfate, aureomyein, chloromycetin or terramyein.
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